Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Current Deferred Revenue (2023 - 2026)

BrightSpring Health Services filings provide 4 years of Current Deferred Revenue readings, the most recent being $9.2 million for Q1 2026.

  • On a quarterly basis, Current Deferred Revenue rose 5.11% to $9.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $9.2 million, a 5.11% increase, with the full-year FY2025 number at $9.0 million, down 11.35% from a year prior.
  • Current Deferred Revenue hit $9.2 million in Q1 2026 for BrightSpring Health Services, up from $9.0 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $30.8 million in Q4 2023 to a low of $8.2 million in Q2 2025.
  • Median Current Deferred Revenue over the past 4 years was $9.7 million (2024), compared with a mean of $15.5 million.
  • Biggest five-year swings in Current Deferred Revenue: plummeted 66.95% in 2024 and later grew 5.11% in 2026.
  • BrightSpring Health Services' Current Deferred Revenue stood at $30.8 million in 2023, then plummeted by 66.95% to $10.2 million in 2024, then fell by 11.35% to $9.0 million in 2025, then increased by 1.52% to $9.2 million in 2026.
  • The last three reported values for Current Deferred Revenue were $9.2 million (Q1 2026), $9.0 million (Q4 2025), and $8.3 million (Q3 2025) per Business Quant data.